Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BI 2536 Second Line Monotherapy in SCLC

This study has been completed.
Information provided by:
Boehringer Ingelheim Identifier:
First received: December 18, 2006
Last updated: April 30, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 30, 2014